FDA NDC Directory · JSON-LD · Markdown

DEFERASIROX

NDC 62332-411 · HUMAN PRESCRIPTION DRUG · TABLET, FILM COATED

Labeler / ManufacturerAlembic Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA211824
Dosage form / routeTABLET, FILM COATED · ORAL
Active ingredientsDEFERASIROX (180 mg/1)
Marketing started20200615
Package count2

External sources

Source: openFDA. Public-domain (CC0).